Paper Details

  1. Home
  2. Paper Details

Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis.

Author: DaraAntoine, DiakiteMahamadou, DjimdéAbdoulaye, DoumbiaSeydou O, KayentaoKassoum, KeitaMakan, LiJian, MaigaFatoumata O, MatherFrances J, RefeldRandi R, SagaraIssaka, ShafferJeffrey G, TangaraCheick Oumar, ThieroOumar, ToureMahamoudou, ToureSounkou M, WeleMamadou

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Artemisinin-based combination therapy (ACT) is the most effective treatment for uncomplicated falciparum malaria. This study will review the effectiveness of ACT in Mali, where malaria is prevalent.
Paper Details　
Original Abstract of the Article :
Artemisinin-based combination therapy (ACT) was deployed in 2005 as an alternative to chloroquine and is considered the most efficacious treatment currently available for uncomplicated falciparum malaria. While widespread artemisinin resistance has not been reported to date in Africa, recent studies...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404312/

データ提供：米国国立医学図書館（NLM）

Artemisinin-Based Combination Therapy for Uncomplicated Plasmodium falciparum Malaria in Mali: A Systematic Review and Meta-Analysis

Malaria is a deadly disease that continues to plague many parts of the world. This research examines the effectiveness of artemisinin-based combination therapy (ACT) for uncomplicated Plasmodium falciparum malaria in Mali, a region with a high malaria burden. The authors conducted a systematic review and meta-analysis to assess the efficacy of ACT in this specific context.

A Powerful Weapon: ACT for Uncomplicated Malaria

The review confirms the high efficacy of ACT in treating uncomplicated falciparum malaria in Mali. Despite concerns about emerging resistance to artemisinin, the authors found no evidence of widespread resistance in this region. The meta-analysis provides strong evidence supporting the continued use of ACT as the first-line treatment for uncomplicated falciparum malaria in Mali.

Combatting Malaria: Implications for Public Health

This research is crucial for guiding public health strategies aimed at controlling malaria. The findings provide a strong basis for continuing to promote the use of ACT in Mali and for monitoring the emergence of any potential resistance. The study underscores the importance of ongoing surveillance and research to ensure the continued effectiveness of ACT in the fight against malaria.

Dr. Camel's Conclusion

My dear friends, imagine a desert where the sun beats down relentlessly and disease lurks in the shadows. This review is like a shield, protecting us from the dangers of malaria. ACT remains a powerful weapon in the fight against this deadly disease, and the study provides reassurance that it continues to be effective in Mali. It's a reminder that even in the face of adversity, we can make progress in controlling disease and improving public health.
Date :
  1. Date Completed 2021-11-04
  2. Date Revised 2023-11-03
Further Info :

Pubmed ID

34461901

DOI: Digital Object Identifier

PMC8404312

Related Literature

Article Analysis
・Effects of artemether and lumefantrine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.